Skip to main content
Premium Trial:

Request an Annual Quote

Ultivue Closes $50M Series D Financing Round

NEW YORK – Tissue imaging firm Ultivue announced Tuesday that it has closed a $50 million Series D financing round.

The Cambridge, Massachusetts-based company said it would use the funds to expand commercialization of its InSituPlex technology and grow its research and development efforts.

The round included previous investors Arch Ventures, Northpond Ventures, and Applied Ventures along with new investors including Ally Bridge Group, Pura Vida Investments, and Tao Capital Partners.

Ultivue's InSituPlex technology uses antibody-DNA barcoding to measure protein biomarkers in tissue with same-slide traditional H&E staining for phenotyping. The company sells its technology for precision medicine research including in cancer immunotherapy.

"Ultivue is driving to make immunotherapy a reality for every patient that needs it with leading technology that enables advanced exploration and interrogation of tissue samples for precision medicine research," Adam Wieschhaus, director at Northpond Ventures, said in a statement.

"We’re excited to welcome our newest investors, and greatly appreciate the support from our existing investment partners," said Jacques Corriveau, president and CEO of Ultivue. "This funding will allow us to expand our commercial efforts while also increasing the scope of our research and development in order to remain at the forefront of innovation and provide biological insights for our customers as they work to address the challenge of therapeutic response rates in patients using immunotherapy."

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.